Development of a revised plant synthetic biology toolkit to advance crop improvement

Grant number: 101060616

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2022
    2024
  • Known Financial Commitments (USD)

    $221,354.05
  • Funder

    European Commission
  • Principal Investigator

    N/A

  • Research Location

    Spain
  • Lead Research Institution

    AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS
  • Research Priority Alignment

    N/A
  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Pre-clinical studies

  • Special Interest Tags

    Innovation

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Agronomy faces significant global challenges such as coping with climate change, a need for more sustainable practices, and an increasing demand for more food of higher quality due to a growing population. Addressing them will require the adoption of transformative innovations, such as the genetic technologies that underlie Plant Synthetic Biology (SynBio). Plant SynBio, through transgenesis and more recently gene editing, allows us to proactively alter plant DNA to modify their characteristics and address the aforementioned challenges. In addition, plant SynBio can enhance the production of high-value, or new compounds in plants by molecular farming. SynBio requires the generation of complex DNA constructs that comprise several transcriptional units, facilitated by the development of modular cloning toolkits and the Phytobrick Standard Syntax, a recent agreement of the plant SynBio community that systematized the sequence requirements for cloning. The aim of REPLANT is to generate a new plant SynBio toolkit based on the Phytobrick architecture that includes the latest developments in protein production and gene editing techniques. The advantages provided by the REPLANT will be demonstrated by two proof-of-concept experiments with biotechnological applications: enhancing the production of SARS-CoV2 recombinant antibodies in plant leaves, and modification of tomato plant architecture in variants of commercial interest. This toolkit, alongside its dissemination approaches will allow a faster advancement of plant SynBio, accelerating the development of improved crops to help solve the global challenges of sustainability and food security.